References

• 2022Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression1,255 cited
• 2021MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study1,091 cited
• 2011Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects970 cited
• 2018Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions562 cited
• 2023Single-Dose Psilocybin Treatment for Major Depressive Disorder538 cited
• 2016Phenomenology, Structure, and Dynamic of Psychedelic States282 cited
• 2019Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis246 cited
• 2021Psychedelics alter metaphysical beliefs228 cited
• 2023Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication179 cited
• 2020Survey of entity encounter experiences occasioned by inhaled N,N -dimethyltryptamine: Phenomenology, interpretation, and enduring effects146 cited
• 2023Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics133 cited
• 2018Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder128 cited
• 2018Behavioral Neurobiology of Psychedelic Drugs102 cited
• 2023Psychedelic therapy in the treatment of addiction: the past, present and future